Can better doctor training stop HPV cancer? huge study aims to find out
NCT ID NCT06831383
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two strategies to help clinics increase HPV vaccination rates among children aged 9-17. One strategy provides online communication training for providers; the other adds a learning collaborative with performance feedback. The goal is to see which approach works best to get more kids their first HPV vaccine dose, ultimately preventing HPV-related cancers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HPV vaccine (Gardasil 9, standard of care)
- What this could lead to
- If successful, this could show how to boost HPV vaccination rates in real-world clinics, preventing thousands of HPV-related cancers each year.
- What could go wrong
- This is a behavioral study, not testing a new vaccine or drug. Success depends on clinics adopting the strategies, and results may vary across different health systems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS VACCINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AMGA
RECRUITINGAlexandria, Virginia, 22314, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.